Bonello William 4
4 · NEOGENOMICS INC · Filed May 2, 2022
Insider Transaction Report
Form 4
Bonello William
VP, Investor Relations
Transactions
- Exercise/Conversion
Common Stock
2022-04-28$7.52/sh+5,727$43,067→ 191,548 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-28−5,727→ 0 totalExercise: $7.52Exp: 2022-04-28→ Common Stock (5,727 underlying)
Holdings
- 37,514
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (37,514 underlying) - 41,167
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (41,167 underlying) - 24,619
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (24,619 underlying) - 45,370
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (45,370 underlying) - 99,772
Stock Option (Right to Buy)
Exercise: $21.41Exp: 2029-03-01→ Common Stock (99,772 underlying)
Footnotes (6)
- [F1]On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F2]On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Mr. Bonello was granted 41,167 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F6]On March 1, 2022, Mr. Bonello was granted 99,772 stock options. These options vest ratably over the first four anniversary dates of the grant date.